2025 HUPO Travel Awards

2025 HUPO Travel Awards is sponsored by Human Proteome Organization (HUPO). Travel awards for PhD students and PostDocs from countries without national funding programs to attend HUPO 2024 as presenters.

Travel Awards - HUPO 2025 Travel award Notifications have now been sent! Important: All travel award applicants have now been notified. If you applied for a travel award for HUPO 2025, you should have received your notification.

Notifications are now available for review. Please check your inbox – and your spam and junk folder – if you have not seen it yet. If you have any questions, please contact hupo2025-program@icsevents.

com . HUPO Awards by National Societies for Master's, or PhD Students, or Postdoctoral Fellows Travel awards by national societies for Master’s, or PhD Students, or Postdoctoral Fellows ranging up to 1,500 USD. HUPO matches the award money provided by national/regional societies up to 40%.

HUPO is aware of the following National Proteomics Societies offering travel award programs for HUPO 2025. Please connect with your national society for further information and application guidelines: Country Society Name Application Link Japan Japan Proteome Society (JPrOS) https://forms. gle/aBmv9mjv8SdpbUNr9 Finland Finnish Proteomics Society (FinnProt) https://www.

finnprot. fi Brazil Brazilian Proteomics Society https://brprot. com.

br/ USA US HUPO https://form. jotform. com/250997279661171 Canada Canadian Proteomics Society https://cnpn.

ca/ France French Proteomics Society https://www. french-proteomics-society. fr/en/grants Australia Australasian Proteomics Society https://www.

australasianproteomics. org/ Switzerland Life Sciences Switzerland – LS2 https://meetings. ls2.

ch/proteomics-2025/general-information Italy Italian Proteomics Association https://www. itpa. it/ UK British Society for Proteomics (BSPR) https://www.

bspr. org/ Germany German Society for Proteome Research (DGPF) https://www. dgpf.

org/stipendien/ EuPA European Proteomics Association (EuPA) https://eupa. org/ Singapore Singapore Society for Mass Spectrometry (SSMS) https://www. ssms.

org. sg/travel-awards China Chinese Proteomics Society http://cnhupo. org.

cn/ Taiwan Taiwan Proteomics Society https://www. proteomics. org.

tw/ https://www. proteomics. org.

tw/ HUPO Travel Awards for Masters, PhD Students, and PhD Graduates with Less than 5 Years These travel awards provide the opportunity for presenters of high rated abstracts from countries without national funding programs to present their work at HUPO and to grow professionally. Awardees will be selected by the HUPO Core Organizing Committee based on the quality of abstracts submitted .

Complimentary full Congress Registration for HUPO 2025. Up to 1,000 USD to help offset travel costs. Masters, PhD Students, and PhD Graduates with less than 5 years.

Must have submitted and accepted an abstract for HUPO 2025 as the Presenter. Must come from a country without a national society providing travel support to attend HUPO 2025. Supporting Documents Required for Applying Curriculum Vitae (max.

2 pages). Personal statement describing how this award would further your professional development in the field of proteomics. Proof of status (i.e. university document, statement from supervisor or senior, etc.) Submitting an abstract to the HUPO 2025 Congress is a mandatory step before you can submit a travel award application.

Visit the ‘ Call for Abstract’ page to submit your abstract. Once your abstract submission is successfully completed , you will receive an abstract submission confirmation email including the link to your personalized Travel Award Application Form.

HUPO Travel Awards for Staff Scientists and Core Lab Managers These travel awards provide the opportunity for non-industry Ph D level staff scientists , lab directors and/or research associate or equivalent who have submitted a high rated abstract to HUPO 2025, to attend this important Congress. Awardees will be selected by the HUPO Core Organizing Committee based on the quality of abstracts submitted .

Complimentary full Congress Registration for HUPO 2025. Up to 1,000 USD to help offset travel costs. Non-industry PhD level staff scientists, lab directors, and/or research associate or equivalent.

Must have submitted and accepted an abstract for HUPO 2025 as the Presenter. Supporting Documents Required for Applying Curriculum Vitae (max. 2 pages).

Short personal statement about why you would like to attend HUPO 2025 and how attending HUPO would foster your professional development in translating “the code of life” utilizing proteotyping/proteomics strategies. (max. 150 words).

Proof of status (i.e. letter from manager). Submitting an abstract to the HUPO 2025 Congress is a mandatory step before you can submit a travel award application. Visit the ‘ Call for Abstract’ page to submit your abstract.

Once your abstract submission is successfully completed , you will receive an abstract submission confirmation email including the link to your personalized Travel Award Application Form.

HUPO Travel Awards for Clinical Scientists Under the motto ‘One World-One Health’, HUPO is encouraging all clinical scientists and fellows to attend HUPO 2025 and is pleased to provide travel awards for those who submitted a highly rated abstract to HUPO 2025. Complimentary full Congress Registration for HUPO 2025. Up to 1,000 USD to help offset travel costs.

Must be a Clinical Scientist/ Fellow (employment in a clinical facility). Must have submitted and accepted an abstract for HUPO 2025 as the Presenter. Supporting Documents Required for Applying Curriculum Vitae (max.

2 pages). Short personal statement about why you would like to attend HUPO 2025 and how attending HUPO would foster your professional development in translating “the code of life” utilizing proteotyping/proteomics strategies. (max.

150 words). Proof of status (i.e. letter head of unit/lab/department). Submitting an abstract to the HUPO 2025 Congress is a mandatory step before you can submit a travel award application.

Visit the ‘ Call for Abstract’ page to submit your abstract. Once your abstract submission is successfully completed , you will receive an abstract submission confirmation email including the link to your personalized Travel Award Application Form. Frequently Asked Questions When will the abstract titles be published online?

Abstract titles will be released J uly 2 3 , 202 4 . When will the full abstracts be published online? The full abstract bodies will be released on August 14, 2024 at 10:00 PDT, except those abstracts included in the WCLC 2024 Press Program.

Abstracts selected for inclusion in the WCLC press program, including Presidential Sessions abstracts, will be kept under embargo until either the time of the presentation or the beginning of the WCLC press conference in which it is presented, whichever comes first. Does WCLC accept abstracts that have been submitted and presented to a previous Conference (ie, encore abstracts, trials in progress encore abstracts)?

An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations during the abstract submission process. Are case reports/case series considered for presentations?

The submission of single case reports is not permitted, however, submission of case series with a minimum of 3 cases but preferably 5, including literature review is accepted. What is the withdraw deadline for regular submissions and late breaking submissions? July 12, 2024 is the withdrawal deadline for regular abstracts and August 9 for LBA abstracts.

The presenting author registration deadline (except LBA abstracts) is July 12, 2024 (23:59 PDT). Abstract presentations for a presenter (except LBA abstracts) not registered by this date will be withdrawn from the program. For late-breaking abstracts, does the Conference only permit abstracts that report on Phase 3 [and higher] studies?

LBA designation will only be given to impactful prospective studies that will change clinical practice within the year and whose data are not available at the time of regular abstract submission due to study events and/or timelines. Examples include randomized phase II and/or III trials, and large single arm phase II trials in rare subtypes of thoracic malignancies.

LBA’s in other disciplines that change clinical practice within the year will also be considered. LBA designation is not a means for extending the regular abstract deadline. Highly impactful studies that have complete data should be submitted as a regular abstract and will be considered for a prominent oral presentation based on scoring by the program committee.

For abstracts that do not meet LBA requirements the authors will be given 48 hours to update the submitted data before the abstracts are re-classified as regular abstracts and rated based on the updated information. Is industry allowed to be in lead or senior author positions on the author list for WCLC abstract submissions? Are there restrictions towards pharmaceutical/commercial authors on presenting abstracts at the meeting?

Yes, industry is permitted to be in the lead and senior author positions in the author list of an abstract. However, Industry/pharmaceutical/commercial authors are prohibited from presenting Presidential, Oral, and Mini Oral presentations. Industry/pharmaceutical/commercial authors are permitted to present poster or e-poster presentations.

Could I send my manuscript to publish to a journal in my country before WCLC? A ssociated manuscript s for any abstract selected for presentation at WCLC can be submitted to a peer reviewed journal prior to presentation at WCLC but must not be published prior to the presentation at WCLC . Simultaneous publications are encouraged.

Would it be possible to submit an abstract without results and conclusion? All Regular Abstracts, Clinical Trials in Progress Abstracts, and Case Series abstracts must be fully completed by the April 5, 2024 deadline. Any Regular Abstracts and Case Series that are incomplete after the April 5, 2024 deadline will be automatically withdrawn and will not be considered for the meeting.

Clinical Trials in Progress abstracts may be submitted and completed by the April 5, 2024 deadline without Results and Conclusions as those sections are optional for CTPS submissions. To submit a late breaking abstract, you must submit a placeholder abstract including all components of the abstract except for the Results and Conclusions by the April 5, 2024 deadline.

Is there a limit on the number of abstracts in which an author can be lead author? Authors can only be listed as the Presenting Author on two (2) abstracts but can be co-author on any number of abstracts. Is there any charge for the submission of abstracts, and if so, how much is it?

There is no charge to submit an abstract to WCLC. Is the presenting author required to be an IASLC member? Does the abstract submission need to be sponsored by an IASLC member?

The authors of the abstract, however, IASLC reserves the right to sell and retain any revenue/income from selling the abstracts, presentation materials or recordings of the presentations. Please refer to the detailed terms and conditions that authors have to agree to during the abstract submission. Do clinical trials need to be registered at clinicaltrials.

gov? The clinical trials must be registered in clinicaltrials. gov or an applicable one from their country/regulatory body.

Can I present my abstract virtually at WCLC 2024? No. You need to attend WCLC 2024 in person to present your abstract. Does recruitment of patients need to have been started by the abstract submission deadline for Clinical Trials in Progress?

How long after WCLC will the video platform be available? The video platform will be available for 3 months after WCLC. For inquiries, please contact hupo2025-program@icsevents.

com HUPO 2025 Onsite Information Access all necessary details for your HUPO 2025 experience —agenda, venue, and travel info.